Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV
Launched by UNIVERSITY OF MANITOBA · Jan 16, 2020
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
**Trial Summary: Healing Circles: An Intervention for Canadian Indigenous Mothers & Children Affected by IPV**
This clinical trial, called "Healing Circles," is focused on helping Indigenous mothers and their children who have experienced intimate partner violence (IPV). The study is evaluating two programs designed to empower mothers and support their children: the Mother's Empowerment Program and the Kid's Club Program. These programs aim to provide resources, support, and a safe space for healing, specifically tailored to the needs of Indigenous families in Canada.
To participate in this trial, mothers must be English-speaking, have experienced intimate partner violence in the past, and have at least one school-aged child. There are no specific exclusions noted, which means many mothers who meet these criteria could be eligible to join. Participants can expect to take part in activities that focus on personal empowerment and children's well-being, all within a supportive community environment. This trial is currently recruiting, so if you or someone you know fits the criteria, there may be an opportunity to join this important study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • mothers self-reported experience of past intimate partner violence, English-speaking, with at least one school-aged child
- Exclusion Criteria:
- • -
About University Of Manitoba
The University of Manitoba, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive expertise in medical research, public health, and community engagement to conduct rigorous and ethical clinical studies. The institution aims to translate scientific findings into practical applications that enhance patient care and improve health outcomes. Committed to fostering a culture of excellence and integrity, the University of Manitoba prioritizes participant safety and scientific validity in all its clinical research endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calgary, Alberta, Canada
Patients applied
Trial Officials
Caroline Piotrowski, PhD MPH
Principal Investigator
University of Manitoba
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials